NCT04025359View on ClinicalTrials.gov

Effects of Dronabinol in Opioid Maintained Patients

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

May 1, 2026

Study Completion Date

September 1, 2026

Conditions

Pain

Interventions

DRUG

Dronabinol

Dronabinol 2.5 mg

DRUG

Dronabinol

Dronabinol 5 mg

DRUG

Placebo

Placebo

Trial Locations (1)

06516

RECRUITING

VA Healthcare System, West Haven

All Listed Sponsors

collaborator

US Department of Veterans Affairs

FED

lead

Yale University

OTHER